TAOX

TAO Synergies Inc. NASDAQ Listed Jul 2, 2025

Healthcare ·Biotechnology ·US · synaptogen.com

$3.68

-2.90% vs $3.79

Mkt Cap $12.1M

52w Low $3.30 4.4% of range 52w High $11.98

50d MA $4.41 200d MA $5.41

P/E (TTM) -0.3x

EV/EBITDA —

P/B —

Debt/Equity 0.0x

ROE -136.5%

P/FCF —

RSI (14) 51.60

ATR (14) $0.34

Beta 1.74

50d MA $4.41

200d MA $5.41

Avg Volume 114.6K

Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases. Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.

SIC Code

6199

CIK (SEC)

1571934

Phone

9732420005

1185 Avenue of the Americas, 3rd Floor · New York, NY 10036 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
May 13, 2026	AMC	-12.75	-0.46	+96.4%	5.70	+2.6%	+1.4%	-9.7%	-8.2%	-5.2%	+1.3%	—
Feb 25, 2026	AMC	—	-1.04	—	4.56	+1.1%	-8.6%	-6.2%	+6.6%	-0.7%	+12.1%	—
Aug 15, 2025	AMC	—	-11.26	—	8.40	-3.6%	-0.7%	-16.5%	-0.4%	-6.9%	+18.6%	—
Dec 31, 2024	AMC	—	-4.10	—	—	—	—	—	—	—	—	—
Sep 30, 2024	AMC	—	-4.35	—	—	—	—	—	—	—	—	—
Jun 30, 2024	AMC	—	-1.06	—	—	—	—	—	—	—	—	—
Mar 31, 2024	AMC	—	-0.20	—	—	—	—	—	—	—	—	—

Data updated apr 24, 2026 10:42am · Source: financialmodelingprep.com